-+ 0.00%
-+ 0.00%
-+ 0.00%

Vertex Pharmaceuticals Receives FDA's Orphan Designation For Atumelnant To Treat Endogenous Cushing’s Syndrome

Benzinga·10/22/2026 16:16:11
Diffusion vocale

www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1154326